Man Group plc Increases Holdings in Option Care Health, Inc. (NASDAQ:OPCH)

Man Group plc lifted its position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 265.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 463,687 shares of the company's stock after purchasing an additional 336,961 shares during the quarter. Man Group plc owned about 0.27% of Option Care Health worth $10,758,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in OPCH. Wellington Management Group LLP grew its stake in Option Care Health by 84.6% in the 4th quarter. Wellington Management Group LLP now owns 18,325,123 shares of the company's stock worth $425,143,000 after buying an additional 8,400,208 shares in the last quarter. Norges Bank bought a new stake in shares of Option Care Health during the 4th quarter worth $60,219,000. Freestone Grove Partners LP purchased a new position in Option Care Health in the fourth quarter worth $17,487,000. Dimensional Fund Advisors LP increased its stake in Option Care Health by 17.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,988,051 shares of the company's stock valued at $92,518,000 after acquiring an additional 591,042 shares during the last quarter. Finally, Victory Capital Management Inc. increased its stake in Option Care Health by 31.1% in the fourth quarter. Victory Capital Management Inc. now owns 2,125,433 shares of the company's stock valued at $49,310,000 after acquiring an additional 503,840 shares during the last quarter. Hedge funds and other institutional investors own 98.05% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on OPCH shares. Jefferies Financial Group upgraded Option Care Health from a "hold" rating to a "buy" rating and upped their price objective for the stock from $26.00 to $35.00 in a report on Thursday, January 23rd. UBS Group raised Option Care Health from a "neutral" rating to a "buy" rating and upped their target price for the stock from $38.00 to $40.00 in a research note on Wednesday, April 30th. Barrington Research reiterated an "outperform" rating and set a $38.00 price target on shares of Option Care Health in a research report on Wednesday, April 30th. JMP Securities reaffirmed a "market outperform" rating and issued a $36.00 price objective on shares of Option Care Health in a research note on Tuesday, April 22nd. Finally, JPMorgan Chase & Co. lifted their target price on shares of Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research report on Thursday, March 6th. One investment analyst has rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat.com, Option Care Health presently has an average rating of "Moderate Buy" and a consensus target price of $35.50.

Option Care Health Trading Down 2.1%

Shares of Option Care Health stock traded down $0.68 on Thursday, hitting $32.03. The stock had a trading volume of 1,110,277 shares, compared to its average volume of 1,856,115. The stock has a market cap of $5.24 billion, a price-to-earnings ratio of 26.92, a PEG ratio of 2.30 and a beta of 0.76. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $35.53. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The stock's 50-day simple moving average is $33.09 and its two-hundred day simple moving average is $29.17.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, beating the consensus estimate of $0.36 by $0.04. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. The firm had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.26 billion. During the same period in the prior year, the firm posted $0.26 earnings per share. The company's quarterly revenue was up 16.3% compared to the same quarter last year. As a group, sell-side analysts predict that Option Care Health, Inc. will post 1.22 EPS for the current year.

Insider Buying and Selling

In other news, insider Michael Bavaro sold 30,996 shares of the firm's stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the sale, the insider now directly owns 44,974 shares of the company's stock, valued at approximately $1,495,835.24. This trade represents a 40.80% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. 0.64% of the stock is currently owned by insiders.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.